Loading viewer...
investor_presentation
Format: PDF investor_presentation
Valneva's 2023 analyst presentation highlights the company's full year 2022 results and corporate updates in the specialty vaccine sector.
presentation
investor_presentation
28 Pages
LAVA Therapeutics
investor_presentation
Alico Inc
investor_presentation
Nomura Holdings